Cytosorbents Cor (CTSO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 09-2025 | 06-2025 | 03-2025 | 12-2024 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 6,249 | 7,536 | 10,204 | 11,587 | 8,280 |
| Receivables | 7,550 | 7,427 | 7,743 | 7,670 | 7,320 |
| Inventories | 5,281 | 4,002 | 3,710 | 3,019 | 2,733 |
| TOTAL | $20,634 | $21,313 | $22,987 | $25,413 | $21,604 |
| Non-Current Assets | |||||
| PPE Net | 7,823 | 8,193 | 8,466 | 8,723 | 9,002 |
| Intangibles | 3,226 | 0 | 0 | 0 | 3,721 |
| Other Non-Current Assets | 12,499 | 16,244 | 16,537 | 16,646 | 13,045 |
| TOTAL | $23,548 | $24,437 | $25,003 | $25,369 | $25,768 |
| Total Assets | $44,182 | $45,750 | $47,990 | $50,782 | $47,372 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 2,869 | 3,035 | 3,394 | 3,325 | 3,340 |
| Accrued Expenses | 6,299 | 6,559 | 5,953 | 5,937 | 6,032 |
| TOTAL | $9,709 | $10,112 | $9,842 | $9,736 | $9,825 |
| Non-Current Liabilities | |||||
| Long Term Debt | 16,667 | 14,567 | 14,377 | 14,187 | 13,996 |
| Other Non-Current Liabilities | 11,903 | 12,051 | 12,185 | 12,316 | 12,444 |
| TOTAL | $28,570 | $26,618 | $26,562 | $26,503 | $26,440 |
| Total Liabilities | $38,279 | $36,730 | $36,404 | $36,239 | $36,265 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 62,700 | 62,804 | 62,762 | 62,610 | 62,500 |
| Common Shares | 63 | 63 | 63 | 63 | 55 |
| Retained earnings | -312,207 | -306,710 | -303,540 | -305,487 | -304,009 |
| Other shareholders' equity | -2,977 | -3,844 | -3,960 | 1,516 | 4,252 |
| TOTAL | $5,903 | $9,020 | $11,586 | $14,543 | $11,107 |
| Total Liabilities And Equity | $44,182 | $45,750 | $47,990 | $50,782 | $47,372 |